Global Markets for Drug-Device Combinations
Report Scope:
The global market for drug-device combination is a rapidly expanding healthcare industry segment, encompassing products that integrate pharmaceutical drugs with medical devices to enhance treatment efficacy and patient convenience. The current report provides a comprehensive introduction and delves into the market for drug-device combinations. It examines market trends of these products, utilizing data from 2021, estimates for 2024 and projections of compound annual growth rates spanning 2024 through 2029 (forecast period) and regional markets of the drug-device combination product market. This report highlights drug-device combinations’ current and future market potential and a detailed competitive environment analysis. It covers the regulatory scenario, drivers, restraints, challenges, opportunities, emerging technologies and sustainability in drug-device combinations. The report also covers market projections for 2029 and the market share for key market players. The report informs all market players, potential entrants, government agencies and other interested parties. It covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this study helpful.
Report Includes:
The global market for drug-device combination is a rapidly expanding healthcare industry segment, encompassing products that integrate pharmaceutical drugs with medical devices to enhance treatment efficacy and patient convenience. The current report provides a comprehensive introduction and delves into the market for drug-device combinations. It examines market trends of these products, utilizing data from 2021, estimates for 2024 and projections of compound annual growth rates spanning 2024 through 2029 (forecast period) and regional markets of the drug-device combination product market. This report highlights drug-device combinations’ current and future market potential and a detailed competitive environment analysis. It covers the regulatory scenario, drivers, restraints, challenges, opportunities, emerging technologies and sustainability in drug-device combinations. The report also covers market projections for 2029 and the market share for key market players. The report informs all market players, potential entrants, government agencies and other interested parties. It covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this study helpful.
Report Includes:
- 40 data tables and 43 additional tables
- Overview of the global markets for drug-device combination (DDC) products and biological devices
- Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
- Estimate of the current market size and revenue prospects of the global market, along with a market share analysis by product type, application (disease area), and region
- Facts and figures pertaining to the market dynamics, current and emerging technologies, regulations, prospects, product recalls, pipeline products, and the expected impact of macroeconomic factors
- Review of the industry supply chain, using the Porter’s Five Forces model, to analyze the micro%li%and macro environmental factors prevailing in the marketplace
- Overview of ESG developments and sustainability trends in the industry, with a focus on consumer attitudes, companies’ ESG score rankings and their ESG practices
- An analysis of the industry structure, including companies’ market shares, alliances, M&A activity and venture funding outlook
- Profiles of the leading market players, including Medtronic, Boston Scientific Corp., Stryker, Abbott, and BD
CHAPTER 1 EXECUTIVE SUMMARY
Market Outlook
Scope of Report
Market Summary
CHAPTER 2 MARKET OVERVIEW
Market Insights
Regulatory Landscape
Patent Review
Product Recalls
Product Pipeline
CHAPTER 3 MARKET DYNAMICS
Market Dynamics Snapshot
Drivers
Wide Range of Potential Applications of Combinations Products
Growing Prevalence of Chronic Diseases
Empowering Patients: Integrating Homecare Trends with Drug Delivery Advancements
Restraints
Device Reliability and Robustness
Human Factors Testing
Drug and Device Integration
Accommodating Different Volumes
Challenges
Biological Safety Challenges in Drug-Device Combinations
Regulatory Challenges
Opportunities
Technology advancements and Innovative Product Launches
Continuous Growth
Key Players Focusing on Inorganic Strategies in the Drug-Device Combination Products Market
CHAPTER 4 MARKET SEGMENTATION ANALYSIS
Segmentation Breakdown
Drug-Device Combinations Market by Product Type
Drug/Biologic-Device Combination Products
Drug-Biologic Drug-Device Combination Products
Drug, Device and Biologic Combination Products
Drug-Device Combinations Market by Application
Cardiovascular Diseases
Metabolic Disorders
Respiratory Diseases
Wound Care
Oncology
Orthopedic Conditions
Others
Geographic Breakdown
Drug-Device Combinations Market, by Region
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 5 EMERGING TRENDS AND TECHNOLOGIES
Overview
AI in Drug-Device Combination
Nanotechnology
Computational Models and Simulation
Human Organs-on-Chips: Revolutionizing Medical Research
Implantable Drug Delivery Systems
Wireless Implants
Smart Drug Delivery Devices for 3D Printing
Recent Approvals and Launch of Novel Drug-device Combination Products
CHAPTER 6 ESG DEVELOPMENT
Introduction
ESG Sustainability in Drug-Device Combinations Market
ESG Risk Ratings
WHO Guidelines and Global Initiatives
BCC Research Viewpoint
CHAPTER 7 COMPETITIVE LANDSCAPE
Company Share Analysis
Mergers, Acquisitions and Collaborations
Strategic Alliances
CHAPTER 8 APPENDIX
Methodology
Sources
Abbreviations
Company Profiles
3M
ABBOTT
B. BRAUN SE
BD
BOSTON SCIENTIFIC CORP.
JOHNSON & JOHNSON SERVICES INC.
MEDTRONIC
SMITH+NEPHEW
STRYKER
TERUMO CORP.
Market Outlook
Scope of Report
Market Summary
CHAPTER 2 MARKET OVERVIEW
Market Insights
Regulatory Landscape
Patent Review
Product Recalls
Product Pipeline
CHAPTER 3 MARKET DYNAMICS
Market Dynamics Snapshot
Drivers
Wide Range of Potential Applications of Combinations Products
Growing Prevalence of Chronic Diseases
Empowering Patients: Integrating Homecare Trends with Drug Delivery Advancements
Restraints
Device Reliability and Robustness
Human Factors Testing
Drug and Device Integration
Accommodating Different Volumes
Challenges
Biological Safety Challenges in Drug-Device Combinations
Regulatory Challenges
Opportunities
Technology advancements and Innovative Product Launches
Continuous Growth
Key Players Focusing on Inorganic Strategies in the Drug-Device Combination Products Market
CHAPTER 4 MARKET SEGMENTATION ANALYSIS
Segmentation Breakdown
Drug-Device Combinations Market by Product Type
Drug/Biologic-Device Combination Products
Drug-Biologic Drug-Device Combination Products
Drug, Device and Biologic Combination Products
Drug-Device Combinations Market by Application
Cardiovascular Diseases
Metabolic Disorders
Respiratory Diseases
Wound Care
Oncology
Orthopedic Conditions
Others
Geographic Breakdown
Drug-Device Combinations Market, by Region
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 5 EMERGING TRENDS AND TECHNOLOGIES
Overview
AI in Drug-Device Combination
Nanotechnology
Computational Models and Simulation
Human Organs-on-Chips: Revolutionizing Medical Research
Implantable Drug Delivery Systems
Wireless Implants
Smart Drug Delivery Devices for 3D Printing
Recent Approvals and Launch of Novel Drug-device Combination Products
CHAPTER 6 ESG DEVELOPMENT
Introduction
ESG Sustainability in Drug-Device Combinations Market
ESG Risk Ratings
WHO Guidelines and Global Initiatives
BCC Research Viewpoint
CHAPTER 7 COMPETITIVE LANDSCAPE
Company Share Analysis
Mergers, Acquisitions and Collaborations
Strategic Alliances
CHAPTER 8 APPENDIX
Methodology
Sources
Abbreviations
Company Profiles
3M
ABBOTT
B. BRAUN SE
BD
BOSTON SCIENTIFIC CORP.
JOHNSON & JOHNSON SERVICES INC.
MEDTRONIC
SMITH+NEPHEW
STRYKER
TERUMO CORP.
LIST OF TABLES
Summary Table : Global Market for Drug-Device Combinations, by Product Type, Through 2029
Table 1 : EU Combination Product Regulation
Table 2 : Granted Patents on Drug-Device Combination Products in 2024, U.S.
Table 3 : Recalled Drug-Device Combination Products, 2021–2024
Table 4 : Drug-Device Combination Product Pipeline
Table 5 : Projected Number of Adults 50 Years and Older With ?1 Chronic Condition in the United States, 2020–2050
Table 6 : Global Market for Drug-Device Combination Products, by Product Type, Through 2029
Table 7 : Global Market for Drug/Biologic-Device Combination Products, by Product Type, Through 2029
Table 8 : Global Market for Drug Eluting Stents (DES), by Region, Through 2029
Table 9 : Marketed or Late-stage Development Products in DCDs
Table 10 : Global Market for Prefilled Syringe (PFS), by Region, Through 2029
Table 11 : Global Market for Inhalers, by Region, Through 2029
Table 12 : Global Market for Nebulizers, by Region, Through 2029
Table 13 : Global Market for Wound Care Products, by Region, Through 2029
Table 14 : Global Market for Implants, by Region, Through 2029
Table 15 : Available Catheter Types in Clinical Use, 2022
Table 16 : Global Market for Antimicrobial Catheters, by Region, Through 2029
Table 17 : Global Market for Transdermal Patches, by Region, Through 2029
Table 18 : Global Market for Photodynamic Therapy (PDT), by Region, Through 2029
Table 19 : Global Market for Other Types of Drug-Device Combination Products, by Region, Through 2029
Table 20 : Global Market for Drug-Biologic Combination Products, by Product Type, Through 2029
Table 21 : FDA Approved ADCs
Table 22 : Global Market for Antibody Drug Conjugates (ADC), by Region, Through 2029
Table 23 : Global Market for Monoclonal Antibodies (mAbs), by Region, Through 2029
Table 24 : Global Market for Other Types of Drug-Biologic Combination Products, by Region, Through 2029
Table 25 : Global Market for Drug-Device Combination Products, by Application, Through 2029
Table 26 : Global Market for Drug-Device Combination Products for Cardiovascular Diseases, by Region, Through 2029
Table 27 : Global Market for Drug-Device Combination Products for Metabolic Disorders, by Region, Through 2029
Table 28 : Global Market for Drug-Device Combination Products for Respiratory Diseases, by Region, Through 2029
Table 29 : Global Market for Drug-Device Combination Products for Wound Care, by Region, Through 2029
Table 30 : Global Market for Drug-Device Combination Products in Oncology, by Region, Through 2029
Table 31 : Global Market for Drug-Device Combination Products for Orthopedic Conditions, by Region, Through 2029
Table 32 : Global Market for Drug-Device Combination Products for Other Chronic Diseases, by Region, Through 2029
Table 33 : Global Market for Drug-Device Combination Products, by Region, Through 2029
Table 34 : North American Market for Drug-Device Combination Products, by Country, Through 2029
Table 35 : European Market for Drug-Device Combination Products, by Country, Through 2029
Table 36 : Asia-Pacific Market for Drug-Device Combination Products, by Country, Through 2029
Table 37 : ESG Highlights, by Major Players, 2023
Table 38 : ESG Rankings for Major Drug-Device Combinations Manufacturing Companies, 2023
Table 39 : Market Players and the Products They Offer for Various Applications
Table 40 : Mergers and Acquisitions: Drug-Device Combination Products Manufacturers, 2021–2024
Table 41 : Major Strategic Alliances in the Drug-Device Combination Industry, 2021–2024
Table 42 : Information Sources in this Report
Table 43 : Major Abbreviations Used in This Report
Table 44 : 3M: Company Snapshot
Table 45 : 3M: Financial Performance, FY 2022 and 2023
Table 46 : 3M: Products Portfolio
Table 47 : 3M: News/Key Developments, 2023
Table 48 : Abbott: Company Snapshot
Table 49 : Abbott: Financial Performance, FY 2022 and 2023
Table 50 : Abbott: Products Portfolio
Table 51 : Abbott: News/Key Developments, 2024
Table 52 : B Braun SE: Company Snapshot
Table 53 : B Braun SE: Financial Performance, FY 2022 and 2023
Table 54 : B. Braun SE: Products Portfolio
Table 55 : B. Braun SE: News/Key Developments, 2022
Table 56 : BD: Company Snapshot
Table 57 : BD: Financial Performance, FY 2022 and 2023
Table 58 : BD: Product Portfolio
Table 59 : BD: News/Key Developments, 2023
Table 60 : Boston Scientific Corp.: Company Snapshot
Table 61 : Boston Scientific Corp.: Financial Performance, FY 2022 and 2023
Table 62 : Boston Scientific Corp.: Products Portfolio
Table 63 : Boston Scientific Corp.: News/Key Developments, 2024
Table 64 : Johnson & Johnson Services Inc.: Company Snapshot
Table 65 : Johnson & Johnson Services Inc.: Financial Performance, FY 2022 and 2023
Table 66 : Johnson & Johnson Services Inc.: Product Portfolio
Table 67 : Johnson & Johnson Services Inc.: News/Key Developments, 2022
Table 68 : Medtronic: Company Snapshot
Table 69 : Medtronic: Financial Performance, FY 2022 and 2023
Table 70 : Medtronic: Products Portfolio
Table 71 : Medtronic: News/Key Developments, 2024
Table 72 : Smith+Nephew: Company Snapshot
Table 73 : Smith+Nephew: Financial Performance, FY 2022 and 2023
Table 74 : Smith+Nephew: Products Portfolio
Table 75 : Smith+Nephew: News/Key Developments, 2024
Table 76 : Stryker: Company Snapshot
Table 77 : Stryker: Financial Performance, FY 2022 and 2023
Table 78 : Stryker: Products Portfolio
Table 79 : Terumo Corp.: Company Snapshot
Table 80 : Terumo Corp.: Financial Performance, FY 2022 and 2023
Table 81 : Terumo Corp.: Product Portfolio
Table 82 : Terumo Corp.: News/Key Developments, 2023
Summary Table : Global Market for Drug-Device Combinations, by Product Type, Through 2029
Table 1 : EU Combination Product Regulation
Table 2 : Granted Patents on Drug-Device Combination Products in 2024, U.S.
Table 3 : Recalled Drug-Device Combination Products, 2021–2024
Table 4 : Drug-Device Combination Product Pipeline
Table 5 : Projected Number of Adults 50 Years and Older With ?1 Chronic Condition in the United States, 2020–2050
Table 6 : Global Market for Drug-Device Combination Products, by Product Type, Through 2029
Table 7 : Global Market for Drug/Biologic-Device Combination Products, by Product Type, Through 2029
Table 8 : Global Market for Drug Eluting Stents (DES), by Region, Through 2029
Table 9 : Marketed or Late-stage Development Products in DCDs
Table 10 : Global Market for Prefilled Syringe (PFS), by Region, Through 2029
Table 11 : Global Market for Inhalers, by Region, Through 2029
Table 12 : Global Market for Nebulizers, by Region, Through 2029
Table 13 : Global Market for Wound Care Products, by Region, Through 2029
Table 14 : Global Market for Implants, by Region, Through 2029
Table 15 : Available Catheter Types in Clinical Use, 2022
Table 16 : Global Market for Antimicrobial Catheters, by Region, Through 2029
Table 17 : Global Market for Transdermal Patches, by Region, Through 2029
Table 18 : Global Market for Photodynamic Therapy (PDT), by Region, Through 2029
Table 19 : Global Market for Other Types of Drug-Device Combination Products, by Region, Through 2029
Table 20 : Global Market for Drug-Biologic Combination Products, by Product Type, Through 2029
Table 21 : FDA Approved ADCs
Table 22 : Global Market for Antibody Drug Conjugates (ADC), by Region, Through 2029
Table 23 : Global Market for Monoclonal Antibodies (mAbs), by Region, Through 2029
Table 24 : Global Market for Other Types of Drug-Biologic Combination Products, by Region, Through 2029
Table 25 : Global Market for Drug-Device Combination Products, by Application, Through 2029
Table 26 : Global Market for Drug-Device Combination Products for Cardiovascular Diseases, by Region, Through 2029
Table 27 : Global Market for Drug-Device Combination Products for Metabolic Disorders, by Region, Through 2029
Table 28 : Global Market for Drug-Device Combination Products for Respiratory Diseases, by Region, Through 2029
Table 29 : Global Market for Drug-Device Combination Products for Wound Care, by Region, Through 2029
Table 30 : Global Market for Drug-Device Combination Products in Oncology, by Region, Through 2029
Table 31 : Global Market for Drug-Device Combination Products for Orthopedic Conditions, by Region, Through 2029
Table 32 : Global Market for Drug-Device Combination Products for Other Chronic Diseases, by Region, Through 2029
Table 33 : Global Market for Drug-Device Combination Products, by Region, Through 2029
Table 34 : North American Market for Drug-Device Combination Products, by Country, Through 2029
Table 35 : European Market for Drug-Device Combination Products, by Country, Through 2029
Table 36 : Asia-Pacific Market for Drug-Device Combination Products, by Country, Through 2029
Table 37 : ESG Highlights, by Major Players, 2023
Table 38 : ESG Rankings for Major Drug-Device Combinations Manufacturing Companies, 2023
Table 39 : Market Players and the Products They Offer for Various Applications
Table 40 : Mergers and Acquisitions: Drug-Device Combination Products Manufacturers, 2021–2024
Table 41 : Major Strategic Alliances in the Drug-Device Combination Industry, 2021–2024
Table 42 : Information Sources in this Report
Table 43 : Major Abbreviations Used in This Report
Table 44 : 3M: Company Snapshot
Table 45 : 3M: Financial Performance, FY 2022 and 2023
Table 46 : 3M: Products Portfolio
Table 47 : 3M: News/Key Developments, 2023
Table 48 : Abbott: Company Snapshot
Table 49 : Abbott: Financial Performance, FY 2022 and 2023
Table 50 : Abbott: Products Portfolio
Table 51 : Abbott: News/Key Developments, 2024
Table 52 : B Braun SE: Company Snapshot
Table 53 : B Braun SE: Financial Performance, FY 2022 and 2023
Table 54 : B. Braun SE: Products Portfolio
Table 55 : B. Braun SE: News/Key Developments, 2022
Table 56 : BD: Company Snapshot
Table 57 : BD: Financial Performance, FY 2022 and 2023
Table 58 : BD: Product Portfolio
Table 59 : BD: News/Key Developments, 2023
Table 60 : Boston Scientific Corp.: Company Snapshot
Table 61 : Boston Scientific Corp.: Financial Performance, FY 2022 and 2023
Table 62 : Boston Scientific Corp.: Products Portfolio
Table 63 : Boston Scientific Corp.: News/Key Developments, 2024
Table 64 : Johnson & Johnson Services Inc.: Company Snapshot
Table 65 : Johnson & Johnson Services Inc.: Financial Performance, FY 2022 and 2023
Table 66 : Johnson & Johnson Services Inc.: Product Portfolio
Table 67 : Johnson & Johnson Services Inc.: News/Key Developments, 2022
Table 68 : Medtronic: Company Snapshot
Table 69 : Medtronic: Financial Performance, FY 2022 and 2023
Table 70 : Medtronic: Products Portfolio
Table 71 : Medtronic: News/Key Developments, 2024
Table 72 : Smith+Nephew: Company Snapshot
Table 73 : Smith+Nephew: Financial Performance, FY 2022 and 2023
Table 74 : Smith+Nephew: Products Portfolio
Table 75 : Smith+Nephew: News/Key Developments, 2024
Table 76 : Stryker: Company Snapshot
Table 77 : Stryker: Financial Performance, FY 2022 and 2023
Table 78 : Stryker: Products Portfolio
Table 79 : Terumo Corp.: Company Snapshot
Table 80 : Terumo Corp.: Financial Performance, FY 2022 and 2023
Table 81 : Terumo Corp.: Product Portfolio
Table 82 : Terumo Corp.: News/Key Developments, 2023
LIST OF FIGURES
Summary Figure : Global Market for Drug-Device Combinations, by Product Type, 2021–2029
Figure 1 : U.S. FDA Combination Product Approval Pathway
Figure 2 : Snapshot of the Global Markets for Drug-Device Combinations
Figure 3 : Share of New Cancer Cases (Incidence) Globally, by Region, 2022
Figure 4 : Share of Cancer Mortality Cases Globally, by Region, 2022
Figure 5 : Global Market Shares of Drug-Device Combination Products, by Product Type, 2023
Figure 6 : Global Market for Drug-Device Combination Products, by Region, 2021–2029
Figure 7 : Global Market Shares of Drug-Device Combination Products, by Region, 2023
Figure 8 : Traditional and New Generation Drug-Device Combination
Figure 9 : Global Market Shares of Drug-Device Combination Products, by Company, 2023
Figure 10 : 3M: Revenue Share, by Country/Region, FY 2023
Figure 11 : 3M: Revenue Share, by Business Unit, FY 2023
Figure 12 : Abbott: Revenue Share, by Country/Region, FY 2023
Figure 13 : Abbott: Revenue Share, by Business Unit, FY 2023
Figure 14 : B Braun SE: Revenue Share, by Country/Region, FY 2023
Figure 15 : B Braun SE: Revenue Share, by Business Unit, FY 2023
Figure 16 : BD: Revenue Share, by Country/Region, FY 2023
Figure 17 : BD: Revenue Share, by Business Unit, FY 2023
Figure 18 : Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2023
Figure 19 : Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2023
Figure 20 : Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, FY 2023
Figure 21 : Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023
Figure 22 : Medtronic: Revenue Share, by Country/Region, FY 2023
Figure 23 : Medtronic: Revenue Share, by Business Unit, FY 2023
Figure 24 : Smith+Nephew: Revenue Share, by Country/Region, FY 2023
Figure 25 : Smith+Nephew: Revenue Share, by Business Unit, FY 2023
Figure 26 : Stryker: Revenue Share, by Country/Region, FY 2023
Figure 27 : Stryker: Revenue Share, by Business Unit, FY 2023
Figure 28 : Terumo Corp.: Revenue Share, by Country/Region, FY 2023
Figure 29 : Terumo Corp.: Revenue Share, by Business Unit, FY 2023
Summary Figure : Global Market for Drug-Device Combinations, by Product Type, 2021–2029
Figure 1 : U.S. FDA Combination Product Approval Pathway
Figure 2 : Snapshot of the Global Markets for Drug-Device Combinations
Figure 3 : Share of New Cancer Cases (Incidence) Globally, by Region, 2022
Figure 4 : Share of Cancer Mortality Cases Globally, by Region, 2022
Figure 5 : Global Market Shares of Drug-Device Combination Products, by Product Type, 2023
Figure 6 : Global Market for Drug-Device Combination Products, by Region, 2021–2029
Figure 7 : Global Market Shares of Drug-Device Combination Products, by Region, 2023
Figure 8 : Traditional and New Generation Drug-Device Combination
Figure 9 : Global Market Shares of Drug-Device Combination Products, by Company, 2023
Figure 10 : 3M: Revenue Share, by Country/Region, FY 2023
Figure 11 : 3M: Revenue Share, by Business Unit, FY 2023
Figure 12 : Abbott: Revenue Share, by Country/Region, FY 2023
Figure 13 : Abbott: Revenue Share, by Business Unit, FY 2023
Figure 14 : B Braun SE: Revenue Share, by Country/Region, FY 2023
Figure 15 : B Braun SE: Revenue Share, by Business Unit, FY 2023
Figure 16 : BD: Revenue Share, by Country/Region, FY 2023
Figure 17 : BD: Revenue Share, by Business Unit, FY 2023
Figure 18 : Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2023
Figure 19 : Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2023
Figure 20 : Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, FY 2023
Figure 21 : Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023
Figure 22 : Medtronic: Revenue Share, by Country/Region, FY 2023
Figure 23 : Medtronic: Revenue Share, by Business Unit, FY 2023
Figure 24 : Smith+Nephew: Revenue Share, by Country/Region, FY 2023
Figure 25 : Smith+Nephew: Revenue Share, by Business Unit, FY 2023
Figure 26 : Stryker: Revenue Share, by Country/Region, FY 2023
Figure 27 : Stryker: Revenue Share, by Business Unit, FY 2023
Figure 28 : Terumo Corp.: Revenue Share, by Country/Region, FY 2023
Figure 29 : Terumo Corp.: Revenue Share, by Business Unit, FY 2023
